logo
Plus   Neg
Share
Email

West Pharmaceutical Services To Replace Helmerich & Payne In S&P 500

S&P Dow Jones Indices said that S&P MidCap 400 constituent West Pharmaceutical Services Inc. (WST) will replace Helmerich & Payne Inc. (HP) in the S&P 500.

Helmerich & Payne will replace J.C. Penney Company Inc. (JCP) in the S&P SmallCap 600, and Physicians Realty Trust (DOC) will replace West Pharmaceutical Services in the S&P MidCap 400.

S&P Dow Jones Indices stated that J.C. Penney filed to reorganize under Chapter 11 of the U.S. Bankruptcy Code and is no longer eligible for continued inclusion in the S&P SmallCap 600.

Helmerich & Payne has a market capitalization that is more representative of the small-cap market space.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Intel Corp. said it is probing into the hack of its fourth-quarter earnings report that prompted the chipmaker to release its earnings statement ahead of schedule. The company, which was scheduled to release the results after the market closed, released it before the market closing on Thursday. Google parent Alphabet decided to drop its Internet balloon project Loon that was launched with the idea of providing Internet access to rural areas and providing last mile connectivity. In a blog post, Loon CEO Alastair Westgarth said they have not found a way to get the costs low enough to build a long-term, sustainable business, despite gaining a number of interested partners along the way. American Airlines announced the launch of Flagship Cellars, its home delivery service for premium wines usually available onboard. The airline's move is said to be due to the excess wine it has amid the weakness in air travel demand following the coronavirus pandemic crisis. The company expects the new at-home wine program to generate about $40,000 to $50,000 in sales during the first quarter.
Follow RTT